CSIMarket Company Name, Ticker, Competitors, else..


Usana Health Sciences Inc   (NYSE: USNA)
Other Ticker:  
 

Usana Health Sciences Inc

USNA's Fundamental analysis



Usana Health Sciences Inc 's sales fell by -3.47 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 1820

Legal Cannabis industry recorded growth of revenues by 5.92 %

Usana Health Sciences Inc 's net profit decreased by -73.26 % in IV. Quarter 2024 year on year, to $4 millions.

• More on USNA's Growth


Usana Health Sciences Inc
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Usana Health Sciences Inc realized cash reduction of $ -7.75 per share in trailing twelve-month period.
Legal Cannabis industry recorded net loss in trailing twelve months.
Company
12.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.63.
Legal Cannabis industry's Price to Sales ratio is at 9.58.


• More on USNA's Valuation
 
 Total Debt (Millions $) 23
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 502,524
 Net Income/Employee (TTM) $ 24,741
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 12.30

Usana Health Sciences Inc
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Usana Health Sciences Inc realized cash outflow of $ -7.75per share in trailing twelve-month period.
Legal Cannabis industry recorded net loss in trailing twelve months.
Company
12.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.63.
Legal Cannabis industry's Price to Sales ratio is at 9.58.

Usana Health Sciences Inc Price to Book Ratio is at 1.01 lower than Industry Avg. of 666.72. and higher than S&P 500 Avg. of 0.01

• More on USNA's Valuation

•  Market Capitalization (Millions $) 535
•  Shares Outstanding (Millions) 19
•  Employees 1,700
•  Revenues (TTM) (Millions $) 854
•  Net Income (TTM) (Millions $) 42
•  Cash Flow (TTM) (Millions $) -149
•  Capital Exp. (TTM) (Millions $) -10
•  Total Debt (Millions $) 23
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 502,524
•  Net Income/Employee(TTM) $ 24,741
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 12.30

•  Market Capitalization (Millions $) 535
•  Shares Outstanding (Millions) 19
•  Employees 1,700
•  Revenues (TTM) (Millions $) 854
•  Net Income (TTM) (Millions $) 42
•  Cash Flow (TTM) (Millions $) -149
•  Capital Exp. (TTM) (Millions $) -10


    USNA's Profitability Comparisons
Usana Health Sciences Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.84 % from 7.8 % in III. Quarter.

Usana Health Sciences Inc net profit margin of 2.09 % is currently ranking no. 7 in Legal Cannabis industry, ranking no. 81 in Consumer Non Cyclical sector and number 2167 in S&P 500.


Profitability by Segment
Total 5.3 %



  Ratio
•   Capital Ratio (MRQ) 2
•  Total Debt to Equity (MRQ) 0.04
•  Tangible Leverage Ratio (MRQ) 0.92
•  Asset Turnover Ratio (TTM) 1.3
•  Inventory Turnover Ratio (TTM) 2.51



Usana Health Sciences Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 3.84 % from 7.8 % in III. Quarter.

Usana Health Sciences Inc net profit margin of 2.09 % is currently ranking no. 7 in Legal Cannabis industry, ranking no. 81 in Consumer Non Cyclical sector and number 2167 in S&P 500.

• More on USNA's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com